asthma
ASTHMA
Asthma is a chronic inflammatory disease of the airways in the lungs of children and adults.
The patient usually complains of shortness of breath, chest tightness and coughing with wheezing.
Goals of treatment are effective symptom control with minimal or no exacerbations, minimal or no nocturnal and daytime symptoms, no limitations on activities, minimal or no need for reliever treatment, and minimal adverse effects of medication.

Definition

  • Defined as a heterogeneous disease characterized by chronic airway inflammation that results in recurrent episodes of wheeze, shortness of breath (SOB), chest tightness &/or cough that vary over time & in intensity, with variable expiratory airflow limitation

Signs and Symptoms

  • Symptoms are usually associated with airflow obstruction; which is often reversible either spontaneously or with treatment
  • These symptoms tend to be intermittent, variable, worse at night or upon waking, & provoked by triggers, eg exercise, allergens, weather changes, viral infections

Risk Factors

  • Asthma phenotypes (clusters of asthma characteristics) differ in clinical manifestations, pathophysiology & demographic location of the patient
    • Allergic asthma: present in childhood, with a positive family history of asthma, & previous history of allergy such as eczema, food allergy, allergic rhinitis, etc
    • Non-allergic asthma: also called adult-onset; asthma presenting & diagnosed for the 1st time in adult years
    • Asthma with fixed airflow limitation: airway wall remodeling due to chronic airway inflammation causing irreversible airflow obstruction
    • Asthma with obesity: prevalence of symptomatic asthma is increased in those suffering from obesity
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Respirology - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
Pearl Toh, 19 Jun 2016
Infants with persistent rhinitis have a higher abundance of Actinobacteria, especially Corynebacterium spp., in their nasal microbiome compared with healthy controls, according to a Singapore-based study presented at the European Academy of Allergy and Clinical Immunology (EAACI) Annual Congress 2016 held in Vienna, Austria.
29 Nov 2017
Lansoprazole, a widely available and commonly prescribed proton pump inhibitor (PPI), appears to reduce the incidence of tuberculosis disease, a recent study has found.
Gabriel Angelo Sembrano, 16 Sep 2014

“At present, there is a limited development of new antibiotics. There is also a fast development of resistance to antibiotics. There are pathogens no longer susceptible to all antibiotics, and many pathogens are no longer susceptible to most antibiotics,” said Dr. Andre Villanueva, chief of party of the USAID’s Innovations and Multisectoral Partnerships to Achieve Control of TB (IMPACT) Project at the recent Annual Convention of the Philippine Pharmacists’ Association in Davao City.

Pearl Toh, 31 May 2016
Synbiotic mixture of oligosaccharides and Bifidobacterium breve (B. breve) M-16V probiotic strain in infant formula restores gut colonisation by B. breve and supports healthy gut development in infants delivered by Caesarean-section (C-section), according to a study presented at the recent European Society for Paediatric Gastroenterology Hepatology and Nutrition (ESPGHAN) annual meeting held in Athens, Greece.